St. Louis, MO startup EndoStim is developing an implantable stimulator to treat gastro-esophageal reflux disease (GERD) by delivering stimulation to the lower esophageal sphincter. The IPG is connected to an EndoStim implantable bipolar lead with electrodes that are stitched and secured into the lower esophageal sphincter muscle during laparoscopy.
EndoStim’s stimulator is intended to treat the root cause of GERD, which according to the company is a weak or dysfunctional lower esophageal sphincter that allows for reflux into the esophagus.
Company website: www.endostim.com
Click here for EndoStim’s patents.